Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Silver

Showing results (611-620 of 653) with videos related to

Pageof 66
Sort By:
Nature Cancer|January 2, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinomaNatalie L Silver, Jin Dai, Travis D Kerr, et al.
Global Change Biology|October 6, 2017
Networking our science to characterize the state, vulnerabilities, and management opportunities of soil organic matterJennifer W Harden, Gustaf Hugelius, Anders Ahlström, et al.
The Lancet. Neurology|October 12, 2012
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trialMichael D Hill, Renee H Martin, David Mikulis, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Discovery of FabH/FabF inhibitors from natural productsKatherine Young, Hiranthi Jayasuriya, John G Ondeyka, et al.
Science (New York, N.Y.)|April 11, 2020
Intravital imaging of mouse embryosQiang Huang, Malkiel A Cohen, Fernando C Alsina, et al.
Stroke|April 21, 2023
Infarcts in a New Territory: Insights From the ESCAPE-NA1 TrialNishita Singh, Petra Cimflova, Johanna Maria Ospel, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 30, 2014
Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodologyAndrew M Demchuk, Mayank Goyal, Bijoy K Menon, et al.
Science (New York, N.Y.)|January 29, 1999
Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibioticH Rosen, R Hajdu, L Silver, et al.
Stroke|December 9, 2024
Factors Influencing Nerinetide Effect on Infarct Volume in Patients Without Alteplase in the Randomized ESCAPE-NA1 TrialJohanna M Ospel, Mayank Goyal, Bijoy K Menon, et al.
Nature Genetics|May 26, 2015
Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndromeAlicia Guemez-Gamboa, Long N Nguyen, Hongbo Yang, et al.
Pageof 66

Showing results (611-620 of 653) with videos related to

Sort By:
Pageof 66
Nature Cancer|January 2, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinomaNatalie L Silver, Jin Dai, Travis D Kerr, et al.
Global Change Biology|October 6, 2017
Networking our science to characterize the state, vulnerabilities, and management opportunities of soil organic matterJennifer W Harden, Gustaf Hugelius, Anders Ahlström, et al.
The Lancet. Neurology|October 12, 2012
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trialMichael D Hill, Renee H Martin, David Mikulis, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Discovery of FabH/FabF inhibitors from natural productsKatherine Young, Hiranthi Jayasuriya, John G Ondeyka, et al.
Science (New York, N.Y.)|April 11, 2020
Intravital imaging of mouse embryosQiang Huang, Malkiel A Cohen, Fernando C Alsina, et al.
Stroke|April 21, 2023
Infarcts in a New Territory: Insights From the ESCAPE-NA1 TrialNishita Singh, Petra Cimflova, Johanna Maria Ospel, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 30, 2014
Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodologyAndrew M Demchuk, Mayank Goyal, Bijoy K Menon, et al.
Science (New York, N.Y.)|January 29, 1999
Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibioticH Rosen, R Hajdu, L Silver, et al.
Stroke|December 9, 2024
Factors Influencing Nerinetide Effect on Infarct Volume in Patients Without Alteplase in the Randomized ESCAPE-NA1 TrialJohanna M Ospel, Mayank Goyal, Bijoy K Menon, et al.
Nature Genetics|May 26, 2015
Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndromeAlicia Guemez-Gamboa, Long N Nguyen, Hongbo Yang, et al.
Pageof 66